Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CYP2C18 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
BCDIN3D-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
UGT2A2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RNF144A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VNN2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RNF32 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC26A3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
NAALAD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MYOD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IFT122 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF32-AS3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SBF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARMC12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LINC01618 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SMIM2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MET - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on